Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysis

Reduction in Oregon's Medication Dosing Visits After the SARS-CoV-2 Relaxation of Restrictions on Take-home Medication

(2021) John W. McIlveen et al.   Journal of Addiction Medicine

Office-Based Methadone Treatment for Opioid Use Disorder and Pharmacy Dispensing: A Scoping Review

(2021) Dennis McCarty et al.   AMERICAN JOURNAL OF PSYCHIATRY

“It’s like ‘liquid handcuffs”: The effects of take-home dosing policies on Methadone Maintenance Treatment (MMT) patients’ lives

(2021) David Frank et al.   Harm Reduction Journal

Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis

(2021) Ximena A. Levander et al.   Addiction Science & Clinical Practice

Comparison of Driving Times to Opioid Treatment Programs and Pharmacies in the US

(2020) Robert A. Kleinman   JAMA Psychiatry

Drive Times to Opioid Treatment Programs in Urban and Rural Counties in 5 US States

(2019) Paul J. Joudrey et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Opioid use disorder and treatment: challenges and opportunities

(2019) Kim A. Hoffman et al.   BMC HEALTH SERVICES RESEARCH

A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States

(2019) Jamey J. Lister et al.   AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE